DOI QR코드

DOI QR Code

Novel Three-Dimensional Knitted Fabric for Pressure Ulcer Prevention: Preliminary Clinical Application and Testing in a Diabetic Mouse Model of Pressure Ulcers

  • Kim, Sungae (Department of Dermatology, Keimyung University School of Medicine) ;
  • Hong, Jamin (Department of Plastic and Reconstructive Surgery, Keimyung University School of Medicine) ;
  • Lee, Yongseong (Department of Research and Development, Song-i Textile Co., Ltd) ;
  • Son, Daegu (Department of Plastic and Reconstructive Surgery, Keimyung University School of Medicine)
  • Published : 2022.03.15

Abstract

Background Population aging has led to an increased incidence of pressure ulcers, resulting in a social burden and economic costs. We developed a three-dimensional knitted fabric (3-DKF) with a pressure-reducing function that can be applied topically in the early stages of pressure ulcers to prevent progression. Methods We evaluated the effects of the 3-DKF in a streptozotocin-induced diabetes mellitus pressure ulcer mouse model, and the fabric was preliminarily applied to patients. Twelve-week-old male C57BL/6 mice were used for the animal experiments. In the pressure ulcer mouse model, an ischemia-reperfusion injury was created using a magnet on the dorsa of the mice. Pressure was measured with BodiTrak before and after applying the 3-DKF to 14 patients at risk of sacral pressure ulcers. Results In the 3-DKF-applied mice group, the ulcers were shallower and smaller than those in the control group. Compared with the mice in the control group, the 3-DKF group had lower platelet-derived growth factor-α and neutrophil elastase expression, as parameters related to inflammation, and increased levels of transforming growth factor (TGF)-β1, TGF-β3, proliferating cell nuclear antigen, and α-smooth muscle actin, which are related to growth factors and proliferation. Additionally, typical normal tissue staining patterns were observed in the 3-DKF group. In the preliminary clinical analysis, the average skin pressure was 26.2 mm Hg before applying the 3-DKF, but it decreased to an average of 23.4 mm Hg after 3-DKF application. Conclusion This study demonstrated that the newly developed 3-DKF was effective in preventing pressure ulcers through testing in a pressure ulcer animal model and preliminary clinical application.

Keywords

Acknowledgement

This work was supported by the R&D Program (S2097930) funded by the Small and Medium Business Administration (SMBA, Korea).

References

  1. Demarre L, Van Lancker A, Van Hecke A, et al. The cost of prevention and treatment of pressure ulcers: a systematic review. Int J Nurs Stud 2015;52(11):1754-1774 https://doi.org/10.1016/j.ijnurstu.2015.06.006
  2. Frankel H, Sperry J, Kaplan L. Risk factors for pressure ulcer development in a best practice surgical intensive care unit. Am Surg 2007;73(12):1215-1217 https://doi.org/10.1177/000313480707301203
  3. Yokoseki T, Kobayashi T, Nishizawa M. Use of a specially designed air-mat for the prevention of decubitus ulcer [in Japanese]. Kango Gijutsu 1977;23(08):57-63
  4. Mita K, Akataki K, Itoh K, Yoshida M, Shinoda T, Ishida Y. Physical characteristics of a new synthetic fiber mattress in relation to pressure sores. Front Med Biol Eng 1997;8(03):221-230
  5. Stuque AG, Sasaki VDM, da Silva Teles AA, et al. Protocolo para prevencao de ulcera por pressao. Revista da Rede de Enfermagem do Nordeste 2017;18:272-282 https://doi.org/10.15253/2175-6783.2017000200018
  6. Wilborn D, Halfens R, Dassen T. Pressure ulcer: prevention protocols and prevalence. J Eval Clin Pract 2006;12(06):630-638 https://doi.org/10.1111/j.1365-2753.2006.00631.x
  7. Black J, Clark M, Dealey C, et al. Dressings as an adjunct to pressure ulcer prevention: consensus panel recommendations. Int Wound J 2015;12(04):484-488 https://doi.org/10.1111/iwj.12197
  8. Clark M, Black J, Alves P, et al. Systematic review of the use of prophylactic dressings in the prevention of pressure ulcers. Int Wound J 2014;11(05):460-471 https://doi.org/10.1111/iwj.12212
  9. Stadler I, Zhang R-Y, Oskoui P, Whittaker MS, Lanzafame RJ. Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse. J Invest Surg 2004;17(04):221-227 https://doi.org/10.1080/08941930490472046
  10. Bergstrom N, Demuth PJ, Braden BJ. A clinical trial of the Braden scale for predicting pressure sore risk. Nurs Clin North Am 1987;22(02):417-428 https://doi.org/10.1016/S0029-6465(22)01289-0
  11. Medical Advisory Secretariat. Pressure ulcer prevention: an evidence-based analysis. Ont Health Technol Assess Ser 2009;9(02):1-104
  12. Wang X-J, Han G, Owens P, Siddiqui Y, Li AG. Role of TGF beta-mediated inflammation in cutaneous wound healing. J Investig Dermatol Symp Proc 2006;11(01):112-117 https://doi.org/10.1038/sj.jidsymp.5650004
  13. Bandyopadhyay B, Fan J, Guan S, et al. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol 2006;172(07):1093-1105 https://doi.org/10.1083/jcb.200507111
  14. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16(05):585-601 https://doi.org/10.1111/j.1524-475X.2008.00410.x
  15. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009;37(05):1528-1542 https://doi.org/10.1177/147323000903700531
  16. Barrientos S, Brem H, Stojadinovic O, Tomic-Canic M. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen 2014;22(05):569-578 https://doi.org/10.1111/wrr.12205
  17. Hanft JR, Pollak RA, Barbul A, et al. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. J Wound Care 2008;17(01):30-32 https://doi.org/10.12968/jowc.2008.17.1.27917
  18. Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA-protein interactions for genome stability. Nat Rev Mol Cell Biol 2013;14(05):269-282 https://doi.org/10.1038/nrm3562
  19. Bazrafshan A, Owji M, Yazdani M, Varedi M. Activation of mitosis and angiogenesis in diabetes-impaired wound healing by processed human amniotic fluid. J Surg Res 2014;188(02):545-552 https://doi.org/10.1016/j.jss.2014.01.041
  20. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63(01):21-29